BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Sunday, March 15, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Aug. 1, 2017
View Archived Issues
GSK reflects on accomplishments of second quarter 2017
Read More
Takeda presents key events of first quarter of fiscal 2017
Read More
Exposure to MeNZB vaccine associated with reduced rates of gonorrhea diagnosis
Read More
First-in-human results for personalized RNA mutanome vaccine IVAC MUTANOME
Read More
FDA grants priority review to RBP-6000 NDA, clearance for buprenorphine assay
Read More
Kite Pharma submits MAA to EMA for axicabtagene ciloleucel
Read More
PellePharm announces topline phase II data for topical patidegib in Gorlin syndrome
Read More
Syndros, the first and only FDA-approved liquid dronabinol, becomes available by prescription
Read More
BLU-667, a RET inhibitor, shows promise for RET-driven thyroid cancer
Read More
Antigen Express and Merck & Co. agree to test AE-37 with Keytruda in triple-negative breast cancer
Read More
BLA submission for trastuzumab biosimilar ABP-980
Read More
Isogenica licenses antibody libraries to Takeda
Read More
FDA grants orphan drug designation to RA-101495 for PNH
Read More
Bayer discloses soluble guanylate cyclase activators
Read More
Aerie collaborates with DSM on technology to deliver compounds for retinal diseases
Read More
FDA accepts for review BLA for trastuzumab biosimilar CT-P6
Read More
Chemerin receptor antagonists presented by Shenzhen Institute of Advanced Technology
Read More
Celgene details pipeline developments of second quarter 2017
Read More
Recro submits NDA for intravenous meloxicam for postoperative pain
Read More
Phase III MAP US study of RHB-104 in Crohn's disease cleared to continue
Read More
New tau PET ligands [18F]AM-PBB3 and [18F]PM-PBB3 evaluated in humans
Read More
Bristol-Myers Squibb and Clovis sign clinical collaboration agreement to test Opdivo with Rubraca
Read More
FDA clears IND for phase I study of PTI-125 for Alzheimer's disease
Read More
Intercept reports results from trials of obeticholic acid in PSC and NASH
Read More
Emergent BioSolutions' development of auto-injector for nerve agent antidote gets financial support
Read More
Kitov announces NDA submission for KIT-302
Read More
Loxo to acquire Redx's BTK inhibitor program
Read More
FDA awards breakthrough therapy designation to acalabrutinib for mantle cell lymphoma
Read More
Lumosa initiates phase I trial of LT-3001 for acute ischemic stroke
Read More
Nerlynx launched in U.S.
Read More
Astellas seeks Japanese approval for fidaxomicin for infectious enteritis caused by C. difficile
Read More
